CannabisNewsBreaks

WednesdayDec 06, 2017 3:28 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Featured in Visual Capitalist Company Spotlight

Pre-clinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) was recently highlighted in a company spotlight article by Visual Capitalist. The article features an infographic that breaks down the company’s development of novel cannabinoid-based therapies from start to finish. Among other areas of interest, Visual Capitalist provided an in-depth look into InMed's Bioinformatics assessment tool, Biosynthesis cannabinoid manufacturing process, and drug pipeline of new cannabinoid treatments. To view the full infographic, visit http://cnw.fm/5afgV About InMed InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery…

Continue Reading

WednesdayDec 06, 2017 10:14 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Inks LOI Formalizing Joint Venture with Smart Cannabis Corp. (SCNA)

SinglePoint (OTC: SING) and Smart Cannabis (OTC: SCNA) have signed a Letter of Intent (“LOI”) to formalize a joint venture relationship. Per this morning’s press release, the two companies are embarking on a multi-purpose joint venture and co-marketing relationship to bring cyber currency payment solutions together with the SMART APP automation software product and the upcoming "Track and Trace Software System," which will be an extension to SinglePoint's current payment processing system. "As we have stated, our overall goal is to have a fully integrated solution for businesses to manage their day-to-day operations from beginning to end, and Smart Cannabis…

Continue Reading

TuesdayDec 05, 2017 11:54 am

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Further Strengthens Positioning in the Cannabis and Industrial Hemp CBD Markets

Marijuana Company of America (OTC: MCOA) has established a commanding presence in the cannabis and industrial hemp cannabidiol ("CBD") markets, as well as the related services supply chain, creating an umbrella over a diverse portfolio of cannabis- and hemp-based companies. In positioning for continued growth of the booming market, with projections that global sales of cannabis will climb to $31.4 billion (http://cnw.fm/Y0xp2), a recent article highlights a strategic joint venture, “In September 2017, MCOA entered into a joint venture with Global Hemp Group Inc. (OTC: GBHPF) (CSE: GHG), a Canadian public company, focused on conducting an industrial hemp pilot program…

Continue Reading

TuesdayDec 05, 2017 10:28 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Enters Joint Venture Agreement with Smart Cannabis Corp. (SCNA)

SinglePoint (OTC: SING) this morning said it has entered a joint venture relationship with Smart Cannabis Corp. (OTC: SCNA) to license and market Smart Cannabis’ SMART app. The industry-specific application permits cannabis cultivators to oversee the entirety of their operations through their mobile device. The two companies will also utilize the partnership to integrate SinglePoint’s bitcoin payment solution and to finalize a track and trace solution. “The transaction from a cultivator to a processor or dispensary can be huge, over $150,000 per transaction, and it is simply not safe or efficient to carry that kind of cash to a transaction.…

Continue Reading

TuesdayDec 05, 2017 10:05 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Enters Agreement with Blockchain BT, LLC to Host a Bitcoin ATM

ChineseInvestors.com (OTCQB: CIIX) today announced an agreement with Blockchain BTM, LLC to host a Bitcoin ATM at its highly-trafficked San Gabriel, California office, allowing cryptocurrency enthusiasts to purchase up to $7,000 worth of Bitcoin daily. Further, CIIX has plans to expand to serve other Chinese communities throughout the United States. In the news release, Warren Wang, Founder and CEO of CIIX, expressed excitement in ATM expansion and additional developments, stating, "In addition to providing skilled investors with news about digital currency, ChineseInvestors.com, Inc. hopes to satisfy the average person's curiosity about cryptocurrency, including how to purchase Bitcoin. Moreover, the underlying…

Continue Reading

TuesdayDec 05, 2017 8:29 am

CannabisNewsBreaks – Veritas Pharma Inc.’s (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Cannevert Subsidiary Inks Material Transfer Agreement with the Institute for Medical Cannabis of Puerto Rico

Emerging pharmaceutical and IP development company Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) today announced that its research arm, Cannevert Therapeutics Ltd. (“CTL”), has signed a Material Transfer Agreement with the Institute for Medical Cannabis Corporation of Puerto Rico. Per the agreement, the Institute for Medical Cannabis will provide CTL with particular cannabis strains for upcoming human studies in the US territory. “We are pleased that Cannevert has identified a reputable producer that is focused on providing certified quality products, educating the medical community on the potential benefits of cannabis, and conducting clinical research on its products. They will…

Continue Reading

MondayDec 04, 2017 1:10 pm

CannabisNewsBreaks – Cannabis Demand in Canada Creates Considerable Opportunity for ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)

As Canada prepares for the legalization of recreational marijuana in July 2018, analysts are noting a shortage of supplies compared to expected demand for cannabis products. The demand is expected to exceed about 1.3 million pounds, easily outpacing current annual production of 20,000 pounds by the country’s licensed producers. That creates tremendous opportunities for Canada’s top cultivators with the ability to expand their operations and increase supply. An article discussing this reads: “ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), has been licensed in good standing since 2014 with no history of product recalls, and proprietary computer-controlled production systems that have bolstered…

Continue Reading

MondayDec 04, 2017 9:04 am

CannabisNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Provides 2018 Strategy Update Regarding Growth Plans

Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) this morning provided an update regarding its growth plans for 2018. The company’s incoming president and CEO Nick Dean intends to focus on meeting the expected surge in demand in the recreational cannabis sector through strategic partnerships and by increasing Emblem’s total production capacity. Dean also intends to ramp up patient acquisition in the medical cannabis market utilizing the company’s strengths and quality products. “Ultimately it’s about being relentlessly driven to deliver a strong return on investment and a solid balance sheet. We will also be mindful of strategic…

Continue Reading

FridayDec 01, 2017 11:41 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Posts Q3 Results, Operational Update

Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) recently released financial results for the three and nine months ended September 30, 2017. Among other highlights from the third quarter, the company reported $43.4 million in cash, cash equivalents and marketable securities which provides a strong position for expansion plans for its high-tech Vanluven facility. Abcann also reported revenues of $614,000 for the nine months ended September 30, 2017, a considerable increase compared to $211,00 during the same period in 2016. Additionally, the company provided an update on operations, including the company’s strategy moving forward. “ABcann’s vision is to create a successful…

Continue Reading

FridayDec 01, 2017 10:46 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Stock, Option and Warrant Transactions

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, this morning announced various stock, option and warrant transactions. The news release states, “Following issuance of these common shares, Lexaria will have 69,674,919 common shares issued and outstanding. No commissions or placement fees have been paid related to the funds received from these warrants exercised. Proceeds will be used for general corporate purposes.” No shares were sold or registered in the United States. In addition, John Docherty, President of Lexaria Bioscience Corp., recently issued a clip discussing the company's technology…

Continue Reading